Repligen Corporation (RGEN) vs West Pharmaceutical Services, Inc. (WST)
- Repligen Corporation RGEN 175.20 −4.87%
- West Pharmaceutical Services, Inc. WST 382.92 −0.03%
Repligen Corporation and West Pharmaceutical Services, Inc. are both Medical Instruments & Supplies companies. West Pharmaceutical Services, Inc. is the larger, with a market value of $27.0B against $11.7B — 2.3× the size. West Pharmaceutical Services, Inc. trades at the lower P/E: 48.7× against 234×. Repligen Corporation grew revenue faster over the last twelve months: 16.5% against 12.4%. West Pharmaceutical Services, Inc. has the higher net margin (17.0% vs 5.29%) and the higher return on invested capital (15.4% vs 2.18%). Across the 22 metrics below, West Pharmaceutical Services, Inc. leads on 14 and Repligen Corporation on 8.
Valuation
Profitability
| Metric | RGEN | WST | Medical Instruments & Supplies median |
|---|---|---|---|
| Gross margin | 53.52% | 36.79% | 54.29% |
| Operating margin | 8.23% | 20.45% | 1.07% |
| Net margin | 5.29% | 16.98% | (1.61%) |
| Free cash flow margin | 14.06% | 13.13% | 1.08% |
| Return on equity | 1.99% | 19.09% | (1.32%) |
| Return on assets | 1.42% | 14.07% | 0.00% |
| Return on invested capital | 2.18% | 15.42% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack